Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: Mission IR

Retrophin, Inc. (RTRX) Starts Presentation at 25th Annual ROTH Conference

Retrophinis a biotechnology company focused on the discovery and development of orphan drugs for the treatment of rare and life-threatening diseases for which there are currently no viable patient options. The company’s lead compound, RE-021, is scheduled to begin enrollment … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Reis, Inc. (REIS) Starts Presentation at 25th Annual ROTH Conference

Reis provides commercial real estate market information and analytical tools for its subscribers through its Reis Services subsidiary. REIS’ database of information on commercial properties in metropolitan markets and neighborhoods is used by real estate investors and lenders, as well … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Actuate Corp. (BIRT) Starts Presentation at 25th Annual ROTH Conference

Actuate is the founder and co-leader of the BIRT open source project, which is used by more than 2 million developers worldwide and serves as the foundation for the ActuateOne platform. Actuate is headquartered in Silicon Valley and has more … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Hudson Technologies, Inc. (HDSN) Starts Presentation at 25th Annual ROTH Conference

Hudson Technologies is a leader in providing solutions for recurring refrigeration industry problems. The company’s proprietary RefrigerantSide Services enhance operating efficiency and energy savings while removing moisture, oils and other contaminants often found in refrigeration circuits of large comfort cooling … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Zenyatta Ventures Ltd. (ZEN) Starts Presentation at 25th Annual ROTH Conference

Zenyatta Ventures is a Canada-based junior exploration company engaged in exploring mining projects. ZEN holds an interest in exploration licenses on properties in the Arc of Fire area in Northern Ontario, Canada. The company’s primary assets consist of the company’s interest … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Nanosphere, Inc. (NSPH) Starts Presentation at 25th Annual ROTH Conference

Nanosphere is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene® System, for direct genomic and ultra-sensitive protein detection. The Verigene System includes molecular diagnostics workstation that is a universal platform for genomic and protein testing. … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Insperity, Inc. (NSP) Starts Presentation at 25th Annual ROTH Conference

Insperity has been a trusted advisor to the best businesses in America for more than 26 years. The company provides a variety of human resources and business solutions that have been created to help improve business performance. Among the company’s … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Microsemi Corp. (MSCC) Starts Presentation at 25th Annual ROTH Conference

Microsemi offers a comprehensive portfolio of semiconductor and system solutions for communications, defense & security, aerospace and industrial markets. The company’s products include high-performance, radiation-hardened and highly reliable analog mixed-signal integrated circuits, FPGAs, SoCs and ASICs; power management products; timing … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Sapiens International Corp. (SPNS) Starts Presentation at 25th Annual ROTH Conference

Sapiens International is a global provider of innovative software solutions for the financial services industry. SPNS offers core, end-to-end solutions for the general insurance, property & casualty, life, pension and annuities markets, and business decision management software, globally. The company … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Medicago, Inc. (MDCGF) Starts Presentation at 25th Annual ROTH Conference

Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins for the treatment of infectious diseases worldwide. The company provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles (VLPs) and manufacturing technologies using a transient expression … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment